Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000001068
Abstract: Supplemental Digital Content is Available in the Text. Background: Vedolizumab (VDZ) is an anti-α4β7 integrin monoclonal antibody approved for inflammatory bowel disease treatment. VDZ serum and antidrug antibody (ADA) concentrations may be used for treatment… read more here.
Keywords: vedolizumab; vdz serum; commercial assays; assay ... See more keywords